A collection of Pink Sheet articles covering evolving EU regulations on clinical trial disclosure and transparency. Pink Sheet provides global policy and regulatory insights for biopharma decision-makers.
As a regulator it is imperative that we are able to take action when absolutely necessary to safeguard patients.